Published in:
12-02-2024 | Original Article
Ventral hernia repair using bioresorbable poly-4-hydroxybutyrate mesh in clean and contaminated surgical fields: a systematic review and meta-analysis
Published in: Hernia | Issue 2/2024
Login to get accessAbstract
Purpose
Use of biologic or synthetic mesh in hernia repair shifts is based on evolving evidence. Poly-4-hydroxybutyrate (P4HB) biosynthetic mesh is a potential alternative to biologic and synthetic mesh in ventral hernia repair (VHR). This meta-analysis assesses the efficacy of P4HB mesh in clean and contaminated surgical settings.
Methods
Two authors searched literature on PubMed, reviewing titles and abstracts of all articles to determine inclusion eligibility. Post-operative data were compared via transformation method to convert the proportion of patients with the outcome of interest into a suitable quantity for random-effects synthesis using STATA software.
Results
Initial search yielded 287 citations. Six studies were included and categorized on whether hernia repairs were conducted in clean (CDC class I) or contaminated cases (CDC class II–IV). The pooled proportion of surgical site infection (SSI), surgical site occurrence (SSO), hernia recurrence, total surgical complications, and reoperation were calculated in 391 clean and 81 contaminated cases. For clean vs. contaminated cases, the following pooled proportions were noted: SSI (2% (CI 0–7%) vs 9% (CI 0–025) (p = 0.03), SSO: 14% (CI 5–25%) vs 35% (CI 22–50%) (p = 0.006), hernia recurrence (8% (CI 1–19%) vs 4% (CI 0–12%) (p = 0.769); surgical complications (17% (CI 6–32%) vs 50% (CI 27–72%) (p = 0.009). Reoperation data were available in 298 clean cases across four studies: 5% (CI 0–15%).
Conclusions
P4HB biosynthetic mesh may be more effective than previously thought, particularly in clean wounds. P4HB may also be superior to biologic mesh when compared to clinical trial data. Further research is necessary for more direct comparison.